Melissa B, Epperly, Director, on June 29, 2026, sold 17,750 shares in Roivant Sciences (ROIV) for $610,252. Following the Form 4 filing with the SEC, Epperly has control over a total of 16,474 common shares of the company, with 16,474 shares held directly.
SEC Filing: